본문 바로가기
KERD
논문KCI 등재

Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류내과학

초록

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and the prevalence of non-alcoholic steatohepatitis (NASH) with fibrosis is increasing as the population with NAFLD ages. To date, lifestyle modifications including weight loss, increased physical activity, and dietary changes remain the treatment of choice for NAFLD because there are no approved effective pharmacologic agents. Increased physical activity has therapeutic effects on NAFLD by reducing hepatic fat independent of weight reduction. Indeed, even minimal physical activity below the recommended threshold may have a beneficial impact on NAFLD. Aerobic activity and resistance training have similar effects on NAFLD. Universal recommendations for the optimal intensity and dose of physical activity have not been established. Therefore, physical activity should be tailored based on a patient’s clinical characteristics, comorbidities, and fitness capacity. Physical activity also prevents the development of NAFLD and may represent a valuable strategy for reducing the public health burden. However, there are insufficient data supporting the effects of physical activity on the progression of non-alcoholic fatty liver to NASH with advanced fibrosis, and on extrahepatic disease- related morbidity and mortality. In this paper, we review the role of physical activity in the management of NAFLD.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and the prevalence of non-alcoholic steatohepatitis (NASH) with fibrosis is increasing as the population with NAFLD ages. To date, lifestyle modifications including weight loss, increased physical activity, and dietary changes remain the treatment of choice for NAFLD because there are no approved effective pharmacologic agents. Increased physical activity has therapeutic effects on NAFLD by reducing hepatic fat independent of weight reduction. Indeed, even minimal physical activity below the recommended threshold may have a beneficial impact on NAFLD. Aerobic activity and resistance training have similar effects on NAFLD. Universal recommendations for the optimal intensity and dose of physical activity have not been established. Therefore, physical activity should be tailored based on a patient’s clinical characteristics, comorbidities, and fitness capacity. Physical activity also prevents the development of NAFLD and may represent a valuable strategy for reducing the public health burden. However, there are insufficient data supporting the effects of physical activity on the progression of non-alcoholic fatty liver to NASH with advanced fibrosis, and on extrahepatic disease- related morbidity and mortality. In this paper, we review the role of physical activity in the management of NAFLD.

참고문헌 (76)

  1. Sayiner M, "Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the united states and the rest of the world", Clin Liver Dis, 20, pp.205~214 (2016)[DOI]
  2. Younossi ZM, "Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008", Clin Gastroenterol Hepatol, 9, pp.524~530 (2011)[DOI]
  3. Satapathy SK, "Epidemiology and natural history of nonalcoholic fatty liver disease", Semin Liver Dis, 35, pp.221~235 (2015)[DOI]
  4. Kwak MS, "Long-term outcomes of nonalcoholic fatty liver disease", Curr Hepatol Rep, 14, pp.69~76 (2015)[DOI]
  5. Paschos P, "Non alcoholic fatty liver disease and metabolic syndrome", Hippokratia, 13, pp.9~19 (2009)
  6. Kwon H, "Body fat distribution and the risk of incident metabolic syndrome: a longitudinal cohort study", Sci Rep, 7, pp.10955~ (2017)[DOI]
  7. Kim D, "Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 14, pp.132~138 (2016)[DOI]
  8. Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112, 2735~2752
  9. Chalasani N, "The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association", Hepatology, 55, pp.2005~2023 (2012)[DOI]
  10. Korean Association for the Study of the Liver (KASL), "KASL clinical practice guidelines: management of nonalcoholic fatty liver disease", Clin Mol Hepatol, 19, pp.325~348 (2013)[DOI]
  11. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases", Hepatology (2017)[DOI]
  12. 정고은, "비알코올 지방간 질환의 역학", 대한내과학회지, 86(4), pp.399~404 (2014), 대한내과학회[DOI]
  13. Younossi ZM, "Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes", Hepatology, 64, pp.73~84 (2016)[DOI]
  14. Estes C, "Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease", Hepatology (2017)[DOI]
  15. Leite NC, "Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus", Liver Int, 29, pp.113~119 (2009)[DOI]
  16. Kim D, "Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States", Hepatology, 57, pp.1357~1365 (2013)[DOI]
  17. Hsu CS, "Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan", J Formos Med Assoc, 111, pp.527~535 (2012)[DOI]
  18. Chen J, "Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography", Radiology, 259, pp.749~756 (2011)[DOI]
  19. Kim D, "Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography", Radiology, 268, pp.411~419 (2013)[DOI]
  20. Nobili V, "Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis", Hepatology, 48, pp.442~448 (2008)
  21. Wong VW, "Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease", Hepatology, 51, pp.454~462 (2010)[DOI]
  22. McPherson S, "Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease", Gut, 59, pp.1265~1269 (2010)[DOI]
  23. Musso G, "Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity", Ann Med, 43, pp.617~649 (2011)[DOI]
  24. Shah AG, "Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 7, pp.1104~1112 (2009)[DOI]
  25. Hamaguchi M, "Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease", World J Gastroenterol, 13, pp.1579~1584 (2007)[DOI]
  26. Kim D, "Nonalcoholic fatty liver disease is associated with coronary artery calcification", Hepatology, 56, pp.605~613 (2012)[DOI]
  27. Park HE, "Nonalcoholic fatty liver disease is associated with coronary artery calcification development: a longitudinal study", J Clin Endocrinol Metab, 101, pp.3134~3143 (2016)[DOI]
  28. Valenti L, "Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?", Liver Int, 36, pp.1563~1579 (2016)[DOI]
  29. Goessling W, "Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease", Gastroenterology, 135, pp.1935~1944 (2008)[DOI]
  30. Lonardo A, "Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome", Dig Liver Dis, 47, pp.181~190 (2015)[DOI]
  31. Calori G, "Fatty liver index and mortality: the Cremona study in the 15th year of follow-up", Hepatology, 54, pp.145~152 (2011)[DOI]
  32. Guturu P, "Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity", Int J Hepatol, 2012, pp.212865~ (2012)
  33. Kim D, "Nonobese fatty liver disease", Clin Gastroenterol Hepatol, 15, pp.474~485 (2017)[DOI]
  34. Armstrong MJ, "Extrahepatic complications of nonalcoholic fatty liver disease", Hepatology, 59, pp.1174~1197 (2014)[DOI]
  35. Targher G, "Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease", N Engl J Med, 363, pp.1341~1350 (2010)[DOI]
  36. European Association for the Study of the Liver (EASL), "EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease", J Hepatol, 64, pp.1388~1402 (2016)
  37. Panagiotakos DB, "Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study", Am Heart J, 147, pp.106~112 (2004)[DOI]
  38. Dalle Grave R, "Lifestyle modification in the management of the metabolic syndrome: achievements and challenges", Diabetes Metab Syndr Obes, 3, pp.373~385 (2010)[DOI]
  39. Perez-Martinez P, "Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation", Nutr Rev, 75, pp.307~326 (2017)[DOI]
  40. Vilar-Gomez E, "Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis", Gastroenterology, 149, pp.367~378 (2015)[DOI]
  41. Orci LA, "Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression", Clin Gastroenterol Hepatol, 14, pp.1398~1411 (2016)[DOI]
  42. Katsagoni CN, "Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: a meta-analysis", Metabolism, 68, pp.119~132 (2017)[DOI]
  43. Oh S, "Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study", Hepatology, 61, pp.1205~1215 (2015)[DOI]
  44. Thoma C, "Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review", J Hepatol, 56, pp.255~266 (2012)[DOI]
  45. Keating SE, "Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis", J Hepatol, 57, pp.157~166 (2012)[DOI]
  46. Thompson PD, "Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)", Circulation, 107, pp.3109~3116 (2003)[DOI]
  47. Pate RR, "Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine", JAMA, 273, pp.402~407 (1995)[DOI]
  48. Fletcher GF, "Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association", Circulation, 104, pp.1694~1740 (2001)[DOI]
  49. Craig CL, "International physical activity questionnaire: 12-country reliability and validity", Med Sci Sports Exerc, 35, pp.1381~1395 (2003)[DOI]
  50. Hashida R, "Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review", J Hepatol, 66, pp.142~152 (2017)[DOI]
  51. Kistler KD, "Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease", Am J Gastroenterol, 10, pp.460~468 (2011)
  52. Houghton D, "Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial", Clin Gastroenterol Hepatol, 15, pp.96~102 (2017)[DOI]
  53. Bacchi E, "Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial)", Hepatology, 58, pp.1287~1295 (2013)[DOI]
  54. Shamsoddini A, "Effect of aerobic and resistance exercise training on liver enzymes and hepatic fat in iranian men with nonalcoholic fatty liver disease", Hepat Mon, 15, pp.e31434~ (2015)
  55. Slentz CA, "Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT", RT, 2011, pp.301, E1033~E1039
  56. Hallsworth K, "Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss", Gut, 60, pp.1278~1283 (2011)[DOI]
  57. Koo BK, "Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis", J Hepatol, 66, pp.123~131 (2017)[DOI]
  58. Keating SE, "Effect of aerobic exercise training dose on liver fat and visceral adiposity", J Hepatol, 63, pp.174~182 (2015)[DOI]
  59. Ryu S, "Relationship of sitting time and physical activity with non-alcoholic fatty liver disease", J Hepatol, 63, pp.1229~1237 (2015)[DOI]
  60. Kwak MS, "Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance", Liver Int, 35, pp.944~952 (2015)[DOI]
  61. Hickman IJ, "A pilot randomised study of the metabolic and histological effects of exercise in non-alcoholic steatohepatitis", J Diabetes Metab, 4, pp.300~ (2013)
  62. Sreenivasa Baba C, "Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis", J Gastroenterol Hepatol, 21(1), pp.191~198 (2006)[DOI]
  63. Keating SE, "The benefits of exercise for patients with non-alcoholic fatty liver disease", Expert Rev Gastroenterol Hepatol, 9, pp.1247~1250 (2015)[DOI]
  64. Barengo NC, "Leisure-time physical activity reduces total and cardiovascular mortality and cardiovascular disease incidence in older adults", J Am Geriatr Soc, 65, pp.504~510 (2017)[DOI]
  65. Barengo NC, "Low physical activity as a predictor for total and cardiovascular disease mortality in middle-aged men and women in Finland", Eur Heart J, 25, pp.2204~2211 (2004)[DOI]
  66. Mora S, "Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study", JAMA, 290, pp.1600~1607 (2003)
  67. Ekelund LG, "Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study", N Engl J Med, 319, pp.1379~1384 (1988)[DOI]
  68. Kodama S, "Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis", JAMA, 301, pp.2024~2035 (2009)[DOI]
  69. Knowler WC, "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin", N Engl J Med, 346, pp.393~403 (2002)[DOI]
  70. Fagard RH, "Exercise characteristics and the blood pressure response to dynamic physical training", Med Sci Sports Exerc, 33(6 Suppl), pp.S484~S492 (2001)[DOI]
  71. Thompson PD, "The acute versus the chronic response to exercise", Med Sci Sports Exerc, 33(6 Suppl), pp.S438~S445 (2001)[DOI]
  72. Couillard C, "Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study", Arterioscler Thromb Vasc Biol, 21, pp.1226~1232 (2001)[DOI]
  73. Kwak MS, "The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease", Liver Int, 37, pp.919~926 (2017)[DOI]
  74. Sung KC, "Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver", J Hepatol, 65, pp.791~797 (2016)[DOI]
  75. Tsunoda K, "Impact of physical activity on nonalcoholic steatohepatitis in people with nonalcoholic simple fatty liver: a prospective cohort study", Prev Med, 88, pp.237~240 (2016)[DOI]
  76. Jan CF, "Exercise might prevent cirrhosis in overweight and obese adults", Liver Int (2017)[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (28건)